⌘K

Login Start Free

Home/Filings/4/0001209191-18-009405

4//SEC Filing

MCGRATH JOHN 4

Accession 0001209191-18-009405

CIK 0001604464other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 8:54 PM ET

Size

4.7 KB

Accession

0001209191-18-009405

Insider Transaction Report

Form 4

Period: 2018-02-09

Atara Biotherapeutics, Inc.ATRA

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2018-02-09$41.70/sh−4,819$200,952→ 105,556 total

Footnotes (1)

[F1]Shares withheld to cover tax obligation from settlement of vested restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1

filerCIK 0001205442

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 8:54 PM ET
Size: 4.7 KB

View on SEC.gov